Researchers reported on a prediction model developed to determine which patients with spinal metastases were likely to benefit from surgery.

The study cohort comprised 186 patients with a mean age of 57.1 ± 13.4 years, 101 of whom were male and 18 of whom had hematologic malignancies. The median survival time was 201 days in the ...

ARLINGTON, Va., May 23, 2024 — The American Society for Radiation Oncology (ASTRO) published today an updated clinical guideline that details best practices for treating patients who have symptomatic ...

Prostate cancer, an uncontrolled growth of cells in the prostate, a gland in the male reproductive system located below the bladder, is one of the most common cancers that affects men, especially in ...

A team of surgeons, anesthesiologists and engineers at the University of Illinois Chicago is studying how lidocaine, a common ...

A private, clinical-stage biopharma company developing small-molecule–based therapies administered directly to treat ...

In August, Plus Therapeutics announced the launch of the CNSide diagnostic platform, a proprietary, highly sensitive, ...